Sandoz CEO Views Trump’s Generics Tariff Threat as Opportunity
Sandoz Group AG Chief Executive Officer Richard Saynor said the move by US President Donald Trump to potentially impose tariffs on generic medicines is more of an opportunity than a...
By Isabel Demetz and Lizzy Burden · Bloomberg
Sandoz Group AG Chief Executive Officer Richard Saynor said the move by US President Donald Trump to potentially impose tariffs on generic medicines is more of an opportunity than a threat to its business.